A clue from nature: Can the bicyclic acetal framework, which is present in many structurally diverse biologically active natural products, be considered a privileged scaffold? Scaffolds with this framework were synthesized and elaborated to give a collection of small-molecule derivatives as potential orally bioavailable lead compounds, and preliminary biological tests gave encouraging results.
No takes yet. Share an insight, caveat, or question.
Milroy et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: